These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 9707372)
21. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome. Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520 [TBL] [Abstract][Full Text] [Related]
23. Acyclovir Sensitivity and Neurovirulence of Herpes Simplex Virus Type 1 with Amino Acid Substitutions in the Viral Thymidine Kinase Gene, Which Were Detected in the Patients with Intractable Herpes Simplex Encephalitis Previously Reported. Inagaki T; Satoh M; Fujii H; Yamada S; Shibamura M; Yoshikawa T; Harada S; Takeyama H; Saijo M Jpn J Infect Dis; 2018 Sep; 71(5):343-349. PubMed ID: 29848849 [TBL] [Abstract][Full Text] [Related]
24. The synergistic effect of IFN-alpha and IFN-gamma against HSV-2 replication in Vero cells is not interfered by the plant antiviral 1-cinnamoyl-3, 11-dihydroxymeliacarpin. Petrera E; Coto CE Virol J; 2006 Jun; 3():45. PubMed ID: 16772029 [TBL] [Abstract][Full Text] [Related]
26. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro. Bourinbaiar AS; Coleman CF Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588 [TBL] [Abstract][Full Text] [Related]
27. Combination of benzo[a]phenothiazines with acyclovir against herpes simplex virus. Mucsi I; Molnár J; Motohashi N Int J Antimicrob Agents; 2001 Jul; 18(1):67-72. PubMed ID: 11463529 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of HSV-1 replication and HSV DNA polymerase by the chloroxoquinolinic ribonucleoside 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid and its aglycone. Souza TM; De Souza MC; Ferreira VF; Canuto CV; Marques IP; Fontes CF; Frugulhetti IC Antiviral Res; 2008 Jan; 77(1):20-7. PubMed ID: 17931712 [TBL] [Abstract][Full Text] [Related]
29. Enhancement of the anti-herpetic effect of trichosanthin by acyclovir and interferon. Zheng YT; Chan WL; Chan P; Huang H; Tam SC FEBS Lett; 2001 May; 496(2-3):139-42. PubMed ID: 11356198 [TBL] [Abstract][Full Text] [Related]
30. A screening dye-uptake assay to evaluate in vitro susceptibility of herpes simplex virus isolates to acyclovir. Danve C; Morfin F; Thouvenot D; Aymard M J Virol Methods; 2002 Sep; 105(2):207-17. PubMed ID: 12270654 [TBL] [Abstract][Full Text] [Related]
32. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells. Saijo M; Suzutani T; Yoshida I Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651 [TBL] [Abstract][Full Text] [Related]
33. Nucleoside metabolism in herpes simplex virus-infected cells following treatment with interferon and acyclovir, a possible mechanism of synergistic antiviral activity. O'Brien WJ; Coe EC; Taylor JL Antimicrob Agents Chemother; 1990 Jun; 34(6):1178-82. PubMed ID: 2393279 [TBL] [Abstract][Full Text] [Related]
34. Synergistic anti-herpes effect of TNF-alpha and IFN-gamma in human corneal epithelial cells compared with that in corneal fibroblasts. Chen SH; Oakes JE; Lausch RN Antiviral Res; 1994 Dec; 25(3-4):201-13. PubMed ID: 7710269 [TBL] [Abstract][Full Text] [Related]
35. Synergistic in vitro interactions between (22S,23S)-3beta-bromo-5alpha,22,23-trihydroxystigmastan-6-one and acyclovir or foscarnet against herpes simplex virus type 1. Talarico LB; Castilla V; Ramirez JA; Galagovsky LR; Wachsman MB Chemotherapy; 2006; 52(1):38-42. PubMed ID: 16340198 [TBL] [Abstract][Full Text] [Related]
36. Effects of epigallocatechin-3-gallate and acyclovir on herpes simplex virus type 1 infection in oral epithelial cells. Wu CY; Yu ZY; Chen YC; Hung SL J Formos Med Assoc; 2021 Dec; 120(12):2136-2143. PubMed ID: 33390306 [TBL] [Abstract][Full Text] [Related]
37. Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity. Burrel S; Bonnafous P; Hubacek P; Agut H; Boutolleau D Antiviral Res; 2012 Dec; 96(3):386-90. PubMed ID: 23041200 [TBL] [Abstract][Full Text] [Related]
38. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity. Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201 [TBL] [Abstract][Full Text] [Related]
39. Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells. Pierce AT; DeSalvo J; Foster TP; Kosinski A; Weller SK; Halford WP J Gen Virol; 2005 Sep; 86(Pt 9):2421-2432. PubMed ID: 16099899 [TBL] [Abstract][Full Text] [Related]
40. Drug resistance patterns of recombinant herpes simplex virus DNA polymerase mutants generated with a set of overlapping cosmids and plasmids. Bestman-Smith J; Boivin G J Virol; 2003 Jul; 77(14):7820-9. PubMed ID: 12829822 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]